By
Drug Target Review2023-11-27T16:00:57
Treating C. elegans with inhibitors of small or large mitochondrial ribosomes extended their median lifespan.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-06-19T08:26:00Z
2026-06-15T12:35:00Z
2025-09-18T12:00:00
Sponsored by Benchling
2024-05-10T11:23:31
Sponsored by BellBrook Labs
2023-03-20T13:41:33
Sponsored by Bio-Techne
2024-01-19T07:40:55
Sponsored by Euretos
2026-06-04T07:05:00
Author Graham Craig
2024-01-26T13:22:42
Sponsored by bit.bio
Site powered by Webvision Cloud